Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, Davis
Prelude Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Duke University
National Cancer Institute (NCI)